Active, not recruitingPhase 3NCT04088409
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
Studying Anterior uveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eli Lilly and Company
- Principal Investigator
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company
- Intervention
- Baricitinib(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 2-17 years · All sexes
- Timeline
- 2019 – 2028
Study locations (20)
- Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre, France
- Hôpital Universitaire Necker Enfants Malades, Paris, France
- Centre Hospitalier Universitaire de Poitiers, Poitiers, France
- Asklepios Klinik Sankt Augustin, Sankt Augustin, North Rhine-Westphalia, Germany
- HELIOS Klinikum Berlin-Buch, Berlin, Germany
- Charité Campus Virchow-Klinikum, Berlin, Germany
- Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari, Hamburg, Germany
- Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Lombardy, Italy
- Azienda Ospedaliero Universitaria Meyer, Florence, Italy
- Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
- Hospital Infantil Universitario Niño Jesús, Madrid, Madrid, Comunidad de, Spain
- Hospital Universitario La Paz, Madrid, Madrid, Comunidad de, Spain
- Hospital Universitario La Fe de Valencia, Valencia, Spain
- Bristol Royal Hospital for Children, Bristol, Bristol, City of, United Kingdom
- Cambridge Clinical Research Facility, Cambridge, Cambridgeshire, United Kingdom
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04088409 on ClinicalTrials.govOther trials for Anterior uveitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07285070Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisNovaliq GmbH
- RECRUITINGPHASE2NCT07552012A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIUShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07218770A Study of REGN7041 for Active Noninfectious Uveitis in Adult ParticipantsRegeneron Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT07262437Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine ProfilesUniversity of Milan
- ACTIVE NOT RECRUITINGPHASE3NCT06431373A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisPriovant Therapeutics, Inc.
- RECRUITINGNCT07065747Quantification & Classification of Inflammatory Cells in Uveitis Using OCTOregon Health and Science University
- RECRUITINGNCT06720376Observational Prospective Turkish Inception Cohort of Uveitis and SpondyloarthritisMarmara University
- RECRUITINGPHASE3NCT05486468The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentTexas Retina Associates